Skip to content

Migrants in European countries who have multiple risk factors are more likely to get tested for HIV than those with fewer risk factors, a study of 2834 migrants in 10 European countries has found.

The study was presented at last week’s International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2026) by Dr Haoyi Wang of Maastricht University in collaboration with the Mi-Health partnership, a European network of migrant health organisations. 

In 2024, migrants accounted for 56% of all new diagnoses of HIV in the European Economic Area (the EU plus Iceland, Liechtenstein and Norway). Dr Wang said that migrants, especially recent arrivals, experience more difficulties in accessing HIV testing and prevention methods than other groups. Studies have found that about 30% of migrants living with HIV acquire HIV after migrating and that the risk in some groups is considerably greater.

One reason often given for high rates of HIV acquisition and low rates of PrEP use and testing is that migrants are “hard to reach”, both due to barriers in supply (e.g. lack of entitlement to healthcare, language barriers) and in demand (e.g. migrants thinking they have ‘left HIV behind’ and are at low risk in their host country).

The Mi-Health study was designed, firstly, to contact migrants and ask about their HIV testing history and, secondly, to examine whether specific characteristics and vulnerabilities, especially in combination, acted as barriers to or incentives to test.

For this study, community-based organisation partners conducted outreach HIV testing between September 2024 and October 2025, in Belgium, Cyprus, France, Germany, Greece, Ireland, Italy, Spain, Sweden and the UK.

In total, 2834 people took a rapid test. Of them 37 (1.3% or one in every 77 tests) was reactive and 32 of those were linked to care and got a confirmatory test. Dr Wang commented that, considering that the rapid tests were largely conducted in ‘pop up’ tents and outreach vans, and there were often “substantial social, linguistic, legal, and administrative barriers” to overcome, the study in itself proved that people described as ‘hard to reach’ can be moved along the care continuum.

Alongside the tests, data was gathered about participants’ testing history, and whether they knew about, had used, or were currently on PrEP. Eighty-seven per cent of testers (2464 people) supplied enough data for analysis, of whom 2176 (88% of survey respondents or 77% of all testers) were migrants. The number in each country ranged from 599 in Belgium to 30 in Ireland.

The researchers then sorted the 2464 people into categories, or rather combinations of categories. These were based on gender/orientation (four categories: man who has sex with men, trans person, heterosexual woman and heterosexual man); migrant status (also four categories: documented/settled, refugee, asylum seeker and undocumented); engaged in sex work (two categorises, yes or no); and injecting drug use (also yes or no). This meant there were 64 possible combinations of status people could have.

Participants were further categorised on the basis of duration of residence, region of origin, and whether or not their host country had a national HIV policy that prioritised testing and prevention for migrants.

Including 288 people who were not migrants, 47% were heterosexual men, 34% heterosexual women, 14% gay and bisexual men and 6% trans and non-binary people. Eight per cent were sex workers and 6% people who injected drugs. Excluding the non-migrants, 54.5% were migrants who had citizenship, leave to remain or had a long-term visa, 7.4% were refugees, 23.4% were asylum seekers and 14.7% were undocumented. 

(Note: though regulations differ by country, the difference between the last three categories is that refugees have had their status as people running from danger accepted, asylum seekers are applying for this status, and undocumented migrants have not yet applied, have had their application refused or are otherwise not in the system.)

Glossary

HIV

Human immunodeficiency virus, the virus which causes AIDS. There are two variants: HIV-1, and HIV-2. HIV-1 is by far the most common worldwide. See ‘subtype’ for more information.

on

Abbreviation of a Latin term meaning every night.

risk

See absolute risk: The chance that a person will experience a specific event during a period of time. It is always between 0 and 1 (when expressed as a probability), or between 0 and 100 (when expressed as a percentage).

significant

See statistical significance: Statistical tests are used to judge whether the results of a study could be due to chance and would not be confirmed if the study was repeated. If result is probably not due to chance, the results are ‘statistically significant’. 

therapy

Any form of treatment. Drugs, radiation, and psychiatric counselling are forms of therapy. 

Just under half of all testers (46%) had never taken an HIV test before, and though a majority of asylum seekers (54%) had never done so, this was not a statistically significant difference. Only 13% of gay and bisexual men and 17% of trans people were first-time testers, but 58% of the heterosexual men had never tested, and this was significant. Only 7% of sex workers and 20% of people who inject drugs had never tested. 

Using an analysis technique called MAIHDA (Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy), Dr Wang and colleagues analysed the data to explore how different combinations of characteristics influenced whether people had tested before. Such ‘intersectional’ status could work synergistically, meaning that a combination of characteristics would make people disproportionately more (or less) likely to have tested before. However, this study found that intersectional status worked additively: people with more than one risk characteristic were more likely to test, but not disproportionately so. Dr Wang explained the distinction with reference to himself: "If it is intersectional, I am a gay Asian. If it is additive, then I am a gay, plus Asian."

Migrants from elsewhere in the WHO European region or the Eastern Mediterranean region were less likely to have tested before. These two regions include eastern Europe and most of the Middle East and North Africa respectively, two parts of the world where HIV diagnoses are still rising. In countries where only certain groups of migrants were included in their HIV testing and prevention policy, migrants were far less likely to have taken an HIV test before. Of note, migrants were less likely to test in countries whose HIV policies made no mention of migrants than in countries that explicitly recommended testing for migrants, but this effect was less pronounced than the impact of selective exclusion on previous testing.

As might be expected, duration of residence affected testing history: compared with people who had arrived less than a year ago, people who had been there up to two years were twice as likely to have had a previous test and people who had been there longer about three times more likely.

Intersectional combinations of characteristics affected whether people were likely to have taken a previous test. So (to take the two extremes), a heterosexual man who was an asylum seeker, not involved in sex work or injecting drugs, and who was living in a country that only prioritised certain categories of migrant for HIV testing, was only about 40% likely to have tested before. On the other hand, a gay or bisexual man who was a refugee, with experience of sex work and injecting drugs and who was living in a country that did not mention migrants in its HIV testing policy was almost 100% likely to have taken a previous HIV test.

This study demonstrated two complementary facts regarding migrants and HIV testing. On the one hand, migrants generally test in accordance with their perceived and actual likelihood of acquiring HIV – and their host country’s HIV testing policy. On the other hand, there is a sizeable population of migrants who have never tested, either in their country of origin or their new country of residence. For these people, community engagement and outreach testing can help reach people considered “hard to reach”.

 

ConferenceHIV Glasgow 2026
Date8-11 November
LocationGlasgow, UK & online

Reference

Wang HY et al. At the margins of the fringe: Intersectional and Structural Inequities in HIV Testing and Healthcare Linkage Among Migrants Across 10 European Countries. International Congress on Drug Therapy in HIV Infection, Glasgow, abstract O39.2, 2026.

Gus Cairns

Gus Cairns

Editorial Consultant

Gus joined aidsmap's editorial team in 2009 and previously edited HIV Treatment Update and Preventing HIV. He retired from full-time work in 2023 and now contributes news and conference reports as a freelancer. He is also co-chair for Combination Prevention at the European AIDS Treatment Group. LinkedIn  |  Facebook

Photo: Steven Doyle

More news

Immigration and poverty tied to heightened HIV risk in the Netherlands

A man sits in a chair, talking to another person whose back is towards the camera.

Vulnerability to HIV among migrants in Switzerland is multidimensional

Mareike Günsche | www.aspect-us.com

Migrants being left behind by the HIV response in Europe

Shutterstock Studios HIV in View gallery